Jan 22 (Reuters) - Shanghai Fosun Pharmaceutical 600196.SS:
SAYS IT PLANS TO BUY BACK 300-600 MILLION YUAN ($41.28-82.57 million) OF COMPANY A-SHARES BETWEEN JAN 22 AND JULY 21
SAYS IT PLANS TO BUY BACK UP TO 27.6 MILLION COMPANY H-SHARES WITHIN SAME PERIOD
SAYS UNIT'S PLAN TO MERGE WITH HENLIUS BIOTECH FAILED TO PASS HENLIUS'S SHAREHOLDER MEETING
Source text
Source text 2
Source text 3
Further company coverage: 600196.SS
($1 = 7.2666 Chinese yuan renminbi)
(Reporting by Beijing Newsroom)
((yukun.zhang@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.